LEADER 03393nam 22006495 450 001 9910806194803321 005 20240127073637.0 010 $a9789819969999 010 $a9819969999 024 7 $a10.1007/978-981-99-6999-9 035 $a(CKB)30119416200041 035 $a(DE-He213)978-981-99-6999-9 035 $a(MiAaPQ)EBC31093798 035 $a(Au-PeEL)EBL31093798 035 $a(OCoLC)1419871596 035 $a(EXLCZ)9930119416200041 100 $a20240127d2023 u| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aChallenges and Solutions Against Visceral Leishmaniasis /$fedited by Angamuthu Selvapandiyan, Ruchi Singh, Niti Puri, Nirmal K. Ganguly 205 $a1st ed. 2023. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2023. 215 $a1 online resource (XXI, 449 p. 36 illus., 34 illus. in color.) 311 08$a9789819969982 327 $aModule 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development. 330 $aThis book comprehensively reviews the epidemiology and surveillance strategies of Visceral Leishmaniasis, and the latest developments in disease diagnosis, drug discovery, and vaccine development. The initial chapters cover the epidemiology features and spatial distribution of Visceral Leishmaniasis. The book further discusses the manifestations of HIV-Visceral Leishmaniasis infection on the immunopathogenesis, diagnosis, and therapeutic response. It analyzes the role of different proteomic technologies in understanding the parasite development, survival, drug resistance mechanisms, host-pathogen interactions, and the development of new therapeutic approaches. The book concludes by discussing recent advancements in vaccine development for Visceral Leishmaniasis. It discusses the promising vaccine candidate, their developmental status, current challenges, and prospects for rational vaccine development against Leishmania. This book is an invaluable source of information for students, and researchers working to understand the Leishmania biology, and drug development. 606 $aParasitology 606 $aDrugs$xDesign 606 $aPharmaceutical chemistry 606 $aEpidemiology 606 $aParasitology 606 $aStructure-Based Drug Design 606 $aPharmaceutics 606 $aEpidemiology 615 0$aParasitology. 615 0$aDrugs$xDesign. 615 0$aPharmaceutical chemistry. 615 0$aEpidemiology. 615 14$aParasitology. 615 24$aStructure-Based Drug Design. 615 24$aPharmaceutics. 615 24$aEpidemiology. 676 $a571.999 702 $aSelvapandiyan$b Angamuthu$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSingh$b Ruchi$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPuri$b Niti$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGanguly$b Nirmal K$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910806194803321 996 $aChallenges and Solutions Against Visceral Leishmaniasis$93907851 997 $aUNINA